Dr., University Geneva
Member of the Board of Directors, Medicine, Research, Regulatory Affairs
Dr. Leila Nobs has been a member of the Board of Directors at InnoMedica since 2025. In addition to her expertise in nanoparticle research, she has an extensive network in the scientific community. She has been with TRB Chemedica International since 2007, currently in the role of Chief Scientific Officer.
Dr. Nobs studied pharmacy at the University of Geneva, where she completed her PhD on nanoparticles for the targeted treatment of cancer cells and later worked as an assistant professor.
